John Michael Maslowski, CEO at Fibrocell Science, Inc. (FCSC), bought 3,000 shares at $2.06 ($6K) on 2018-08-22, disclosed to the SEC on 2018-08-23.
Open-market purchase of $6k FCSC by CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |